Clinical Trial Update: CD133 Transplantation to Generate Oocytes in Poor Ovarian Reserve [NA]

View source ↗

Summary

A clinical trial investigating CD133-positive cell transplantation to address diminished ovarian reserve has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diminished Ovarian Reserve
• Ovarian Insufficiency

Drugs mentioned

• CD133-positive cell transplantation

Snippet

Sponsor: Hospital Universitario La Fe | Conditions: Ovarian Reserve | NA | Status: WITHDRAWN